Choroidal Thickness Association With Primary Angle Closure
NCT ID: NCT03050073
Last Updated: 2018-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2016-04-18
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research on the Diagnosis and Treatment of Angle Closure Glaucoma With Abnormal Lens Zonular
NCT05163093
Macular Pigment Optical Density in Primary Angle-closure Disease
NCT05251792
Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study
NCT06492538
Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
NCT00001161
Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma
NCT00321386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary angle closure confirmed by gonioscopy
* interpretable images for choroidal thickness measure
* interpretable images by Ultra Bio Microscopy (UBM)
Exclusion Criteria
* Rethinopathy (diabetic or hypertensive)
* Histories of intra-eye surgery
* Great myopia
* Hypermetropia
* retinal pathology
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Hôpital Saint-Joseph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène BEAUSSIER, Pharm-D
Role: STUDY_DIRECTOR
CRC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.